SRI-37330 is an orally bioavailable thioredoxin-interacting protein (TXNIP) inhibitor. SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production and reverses hepatic steatosis. SRI-37330 can be used for type 2 diabetes research[1].
Molecular Weight:
388.41
Purity:
99.16
CAS Number:
[2322245-42-9]
Formula:
C16H19F3N4O2S
Target:
Arrestin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted